Skip to main content
. Author manuscript; available in PMC: 2019 Jul 1.
Published in final edited form as: Ophthalmology. 2018 Feb 14;125(7):1037–1046. doi: 10.1016/j.ophtha.2018.01.004

Table 1.

Multivariable model of factors associated with incidence of scar through year 5

Baseline Characteristics Eyes at Risk, N Scar, n (%) Hazard Ratio (95% CI) P-value
Drug group 0.23
 Ranibizumab 526 253 (48%) 1.00
 Bevacizumab 484 256 (53%) 1.15 (0.92, 1.44)
Dosing regimen during first 2 years   0.17
 Pro re nata (PRN) for 2 years 504 248 (49%) 1.00
 Switched from monthly to PRN at 1 year 253 138 (55%) 1.29 (0.98, 1.69)
 Monthly for 2 years 253 123 (49%) 1.02 (0.77, 1.35)
Baseline VA in fellow eye   0.04
 20/50 or worse 308 146 (47%) 1.00
 20/25-20/40 398 186 (47%) 0.97 (0.74, 1.28)
 20/20 or better 304 177 (58%) 1.34 (1.00, 1.79)
Lesion type <0.001
 Occult only 614 224 (36%) 1.00
 Minimally classic 175 121 (69%) 2.74 (2.04, 3.69)
 Predominantly classic 221 164 (74%) 4.49 (3.34, 6.04)
Hemorrhage associated with the lesion <0.001
 None 401 186 (46%) 1.00
 <=1 Disc Area 519 259 (50%) 0.92 (0.73, 1.18)
 >1 Disc Area 90 64 (71%) 2.28 (1.49, 3.47)
Retinal thickness at foveal center (μm) <0.001
 <120 103 44 (43%) 1.00
 120 to 212 541 252 (47%) 1.50 (1.00, 2.24)
 >212 366 213 (58%) 2.58 (1.69, 3.94)
Subretinal fluid thickness at foveal center (μm)   0.01
 =0 668 339 (51%) 1.00
 >0 to <=25 83 49 (59%) 1.84 (1.21, 2.80)
 >25 259 121 (47%) 1.31 (0.97, 1.75)
Subretinal tissue complex thickness at foveal center (μm) <0.001
 >0 to <=75 246 89 (36%) 1.00
 >75 to <=160 244 130 (53%) 1.74 (1.23, 2.46)
 >160 to <=275 257 143 (56%) 1.98 (1.38, 2.82)
 >275 263 147 (56%) 2.64 (1.81, 3.84)
Retinal pigment epithelial elevation   0.002
 Yes 878 419 (48%) 1.00
 No 132 90 (68%) 1.71 (1.21, 2.41)
Subretinal hyperreflective material <0.001
 No 236 71 (30%)   1.00
 Yes 774 438 (57%) 1.72 (1.25, 2.36)

P value from Cox proportional hazards model.

*

51 patients were not included in the multivariate model because of missing value in one or more of the following variables: Lesion type, Hemorrhage associated with the lesion, Retinal thickness at foveal center (μm), Subretinal fluid thickness at foveal center (μm), Subretinal tissue complex thickness at foveal center (μm), Retinal pigment epithelial elevation, Subretinal hyperreflective material. VA = Visual acuity